Innovation at WAMM 2025: Ventinova Medical Presents Ventinova Academy

From November 5 to 8, 2025, the third edition of WAMM 2025 took place in the historic city of Florence (Italy). The event was organized by the World Alliance of Airway Management (WAAM) in collaboration with the Difficult Airway Society (DAS), Society for Airway Management (SAM), and European Airway Management Society (EAMS).

The congress brought together airway management specialists from all over the world, consolidating itself as a key meeting point for anesthesiologists, intensivists, emergency physicians, pulmonologists, head and neck surgeons, and professionals in emergency and critical care services.

Importance of the Event

Airway management continues to be a central challenge in emergency medicine, the operating room, critical care, and prehospital settings. In this sense, WAMM 2025 was significant for several reasons:

• It provided a platform to share the latest scientific and technological innovations in the management of difficult, obstructed, craniofacial, and prehospital airways.
• It offered hands-on workshops, simulation sessions, and live demonstrations, alongside the traditional keynote lectures.
• It fostered interaction between industry, clinicians, and educators, a key factor in translating innovation into clinical practice.
• It promoted the creation of international networks, enhancing collaboration between airway societies and training centers, and reinforcing the global dimension of these challenges.

In summary, WAMM 2025 stood out as a vital forum for advancing safety, education, and technology in airway management.

Notable International Speakers

Among the leading figures participating in WAMM 2025 were the Congress Executive Directors: Prof. Ellen O’Sullivan, Prof. Elizabeth Behringer, and Prof. Anil Patel.
Although the complete list of speakers has not been publicly released, the event featured numerous established airway experts from Europe, North America, and Asia, further highlighting its international character.

Industry Participation and Exhibition Data

The WAMM 2025 sponsorship and exhibition program included a dedicated area designed to maximize interaction between delegates and companies.

While the exact number of exhibitors and participating countries has not been disclosed, the sponsorship brochure notes that previous editions hosted over 1,800 attendees and more than 500 poster communications.
It is therefore reasonable to estimate that this year’s edition included dozens of exhibiting companies from across Europe, North America, and Asia.

Prominent Participation of IES Medical and Its Brand Ventinova®

The Spanish company IES Medical had a notable presence as an exhibitor at WAMM 2025, showcasing the solutions of Ventinova®, a brand recognized for its expertise in Flow Controlled Ventilation (FCV®), developed by its parent company Ventinova Medical B.V.

At its booth, IES Medical–Ventinova presented two key innovations:

• Ventinova Academy: an online learning platform aimed at professionals in ventilation, airway management, and advanced ventilation training, to be launched soon.
• Live demonstration of the Ventrain® device: a manually operated flow-controlled ventilator specially designed for ventilation through a narrow lumen, difficult airways, or “cannot intubate / cannot oxygenate” (CICO) situations.

The presence of IES Medical/Ventinova in this global setting highlights its strong commitment to innovation, education, and international collaboration in airway management and ventilation.

Outlook and Closing Remarks

WAMM 2025 reaffirmed its role as a leading event in the field of airway management. The convergence of science, technology, education, and networking opened new opportunities to enhance patient safety, integrate emerging technologies, and train the next generation of professionals.

In this context, collaboration between industry (such as IES Medical/Ventinova), scientific societies, and educators is essential to drive progress.

We look forward to seeing the outcomes of this congress — from new research initiatives to educational tools like Ventinova Academy — translated into tangible improvements in clinical practice in the near future.